Search

Author/Creator Foley, Michael

4. Half-life extension and non-human primate pharmacokinetic safety studies of i-body AD-114 targeting human CXCR4. Issue 7 (3rd October 2019)

Authors:
Griffiths, Katherine; Binder, Uli; McDowell, William; Tommasi, Rita; Frigerio, Mark; Darby, William G.; Hosking, Chris G.; Renaud, Lionel; Machacek, Matthias; Lloyd, Peter; Skerra, Arne; Foley, Michael
Journal:
MAbs
Issue:
Volume 11:Issue 7(2019)
Page Start:
1331
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Placebo-Controlled Efficacy of Percutaneous Coronary Intervention for Focal and Diffuse Patterns of Stable Coronary Artery Disease. (3rd August 2021)

Authors:
Rajkumar, Christopher A.; Shun-Shin, Matthew; Seligman, Henry; Ahmad, Yousif; Warisawa, Takayuki; Cook, Christopher M.; Howard, James P.; Ganesananthan, Sashiananthan; Amarin, Laura; Khan, Caitlin; Ahmed, Ayesha; Nowbar, Alexandra; Foley, Michael; Assomull, Ravi; Keenan, Niall G.; Sehmi, Joban; K...
Journal:
Circulation
Issue:
Volume 14:Number 8(2021)
Page Start:
e009891
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Recruitment and retention in longitudinal studies of people with intellectual disability: A case study of the Intellectual Disability Supplement to the Irish Longitudinal Study on Ageing (IDS-TILDA). (May 2022)

Authors:
McCarron, Mary; McCausland, Darren; McGlinchey, Eimear; Bowman, Sarah; Foley, Michael; Haigh, Margaret; Burke, Eilish; McCallion, Philip
Journal:
Research in developmental disabilities
Issue:
Volume 124(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗